Literature DB >> 16673209

Beta cell function, insulin resistance and plasma adiponectin concentrations are predictors for the change of postprandial glucose in non-diabetic subjects at risk for type 2 diabetes.

C Thamer1, M Haap, E Heller, L Joel, S Braun, O Tschritter, H Haring, A Fritsche.   

Abstract

Insulin resistance, impaired insulin secretion, and low adiponectin levels have been shown to be predictors for type 2 diabetes. However, it is not yet clear whether these associations (1) are independent of changes in body weight, or (2) are valid for changes in glucose tolerance in the prediabetic state. Sixty-two non-diabetics (50 with normal glucose tolerance) aged 41 +/- 11 years, BMI 30.5 +/- 5.3 kg/m2 (mean +/- SD) were studied twice with a standard oral glucose tolerance test (oGTT, mean follow-up time 3.0 +/- 1.8 years (mean +/- SD) [range 0.5-6.5 years]). Insulin sensitivity and insulin secretion were estimated from oGTT using validated indices. Two-hour blood glucose during oGTT deteriorated over time (baseline 2 h glucose 6.32 +/- 0.21 VS. follow-up 2 h glucose 7.14 +/- 0.22 mM, p < 0.001) while the percentage body fat did not change (32.7 +/- 1.2 VS. 32.6 +/- 1.2%, p = 0.46). Follow-up 2 h blood glucose was predicted by adiponectin (p = 0.01), baseline insulin sensitivity (p = 0.02) and baseline insulin secretion relative to insulin sensitivity (p = 0.03) independent of sex, age, baseline 2 h blood glucose or change in percentage body fat. Our results suggest that low adiponectin levels, insulin resistance and low beta cell function predict the continuous deterioration of glucose tolerance in early prediabetic states, independent of changes in adiposity. Therefore, the early influence of these parameters should be the subject of future prevention programs to prevent deterioration of glucose tolerance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16673209     DOI: 10.1055/s-2006-925204

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  8 in total

Review 1.  Prevention of type 2 diabetes: the strategic approach for implementation.

Authors:  P E H Schwarz; A L Albright
Journal:  Horm Metab Res       Date:  2011-12-07       Impact factor: 2.936

2.  Serum total adiponectin is associated with impaired glucose tolerance in Asian Indian females but not in males.

Authors:  Menghua Luo; Reena Oza-Frank; K M Venkat Narayan; Kuppan Gokulakrishnan; Viswanathan Mohan
Journal:  J Diabetes Sci Technol       Date:  2010-05-01

3.  Biomarkers of adiponectin: plasma protein variation and genomic DNA polymorphisms.

Authors:  Harvest F Gu
Journal:  Biomark Insights       Date:  2009-10-13

4.  Low serum adiponectin predicts 10-year risk of type 2 diabetes and HbA1c independently of obesity, lipids, and inflammation: Whitehall II study.

Authors:  A G Tabák; E J Brunner; M A Miller; S Karanam; P G McTernan; F P Cappuccio; D R Witte
Journal:  Horm Metab Res       Date:  2009-04-15       Impact factor: 2.936

5.  Soluble CD163, adiponectin, C-reactive protein and progression of dysglycaemia in individuals at high risk of type 2 diabetes mellitus: the ADDITION-PRO cohort.

Authors:  Pia Deichgræber; Daniel R Witte; Holger J Møller; Mette V Skriver; Bjørn Richelsen; Marit E Jørgensen; Nanna B Johansen; Annelli Sandbæk
Journal:  Diabetologia       Date:  2016-08-19       Impact factor: 10.122

6.  Identification of novel biomarkers to monitor β-cell function and enable early detection of type 2 diabetes risk.

Authors:  Kirstine J Belongie; Ele Ferrannini; Kjell Johnson; Patricia Andrade-Gordon; Michael K Hansen; John R Petrie
Journal:  PLoS One       Date:  2017-08-28       Impact factor: 3.240

7.  Combined association of maternal and paternal family history of diabetes with plasma leptin and adiponectin in overweight Hispanic children.

Authors:  C Koebnick; L A Kelly; C J Lane; C K Roberts; G Q Shaibi; C M Toledo-Corral; J N Davis; M J Weigensberg; M I Goran
Journal:  Diabet Med       Date:  2008-09       Impact factor: 4.359

8.  Diagnostic and Prognostic Protein Biomarkers of β-Cell Function in Type 2 Diabetes and Their Modulation with Glucose Normalization.

Authors:  Abu Saleh Md Moin; Thozhukat Sathyapalan; Stephen L Atkin; Alexandra E Butler
Journal:  Metabolites       Date:  2022-02-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.